Frequency Therapeutics Inc股价飙升10.40% 市值跌14.41万美元

自选股智能写手2023-10-25

北京时间2023年10月25日02时43分，Frequency Therapeutics Inc（FREQ.us）股票出现异动，股价大幅上涨10.40%。截至发稿，该股报0.275美元/股，成交量6.9125万股，换手率0.19%，振幅16.06%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.80百万美元，每股收益-0.30美元，毛利-1.13百万美元，市盈率-0.13倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2378050032?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-10-25 02:43","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2378050032","market":"us","top_or_hot":-1,"title":"Frequency Therapeutics Inc股价飙升10.40% 市值跌14.41万美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2023年10月25日02时43分，Frequency Therapeutics Inc（FREQ.us）股票出现异动，股价大幅上涨10.40%。截至发稿，该股报0.275美元/股，成交量6.9125万股，换手率0.19%，振幅16.06%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.80百万美元，每股收益-0.30美元，毛利-1.13百万美元，市盈率-0.13倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102502435382fe78ae&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Frequency Therapeutics Inc股价飙升10.40% 市值跌14.41万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrequency Therapeutics Inc股价飙升10.40% 市值跌14.41万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-25 02:43 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102502435382fe78ae&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2023年10月25日02时43分，Frequency Therapeutics Inc（FREQ.us）股票出现异动，股价大幅上涨10.40%。截至发稿，该股报0.275美元/股，成交量6.9125万股，换手率0.19%，振幅16.06%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.80百万美元，每股收益-0.30美元，毛利-1.13百万美元，市盈率-0.13倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102502435382fe78ae&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102502435382fe78ae&s=b","article_id":"2378050032","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023102502435382fe78ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2378050032","pubTimestamp":1698173033,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2023年10月25日02时43分，Frequency Therapeutics Inc股票出现异动，股价大幅上涨10.40%。Frequency Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，联拓生物、Inmed Pharmaceuticals Inc、Tharimmune Inc涨幅较大，Inmed Pharmaceuticals Inc、Transcode Therapeutics Inc、联拓生物较为活跃，换手率分别为2866.72%、513.18%、77.41%，振幅较大的相关个股有Inmed Pharmaceuticals Inc、联拓生物、Tharimmune Inc，振幅分别为155.17%、100.00%、79.09%。Frequency Therapeutics Inc公司简介：Frequency Therapeutics Inc是一家临床阶段的生物技术公司，致力于利用人体的先天生物学来修复或逆转由退行性疾病引起的损伤。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技"},"translate_title":"Frequency Therapeutics Inc. soared 10.40% and lost $144,100 in market value","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FREQ":0.9},"content_text":"北京时间2023年10月25日02时43分，Frequency Therapeutics Inc（FREQ.us）股票出现异动，股价大幅上涨10.40%。截至发稿，该股报0.275美元/股，成交量6.9125万股，换手率0.19%，振幅16.06%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-10.80百万美元，每股收益-0.30美元，毛利-1.13百万美元，市盈率-0.13倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Frequency Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，联拓生物、Inmed Pharmaceuticals Inc、Tharimmune Inc涨幅较大，Inmed Pharmaceuticals Inc、Transcode Therapeutics Inc、联拓生物较为活跃，换手率分别为2866.72%、513.18%、77.41%，振幅较大的相关个股有Inmed Pharmaceuticals Inc、联拓生物、Tharimmune Inc，振幅分别为155.17%、100.00%、79.09%。Frequency Therapeutics Inc公司简介：Frequency Therapeutics Inc是一家临床阶段的生物技术公司，致力于利用人体的先天生物学来修复或逆转由退行性疾病引起的损伤。 其祖细胞激活方法使用分子组合来激活体内的祖细胞以产生功能组织。 其产品候选产品FX-322正在开发用于治疗感音神经性听力损失。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2378050032"}